PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.540.04 (-0.72%)
5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.40%
Negative revenue growth while HUH1V.HE stands at 6.30%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.00%
Negative gross profit growth while HUH1V.HE is at 4.80%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.02%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.02%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-9.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-13.33%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-13.33%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
4.90%
Share change of 4.90% while HUH1V.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
4.90%
Diluted share change of 4.90% while HUH1V.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Dividend reduction while HUH1V.HE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
2.90%
OCF growth under 50% of HUH1V.HE's 30.25%. Michael Burry might suspect questionable revenue recognition or rising costs.
-9.50%
Negative FCF growth while HUH1V.HE is at 47.22%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-36.02%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 64.36%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-12.26%
Negative 5Y CAGR while HUH1V.HE stands at 21.59%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-2.71%
Negative 3Y CAGR while HUH1V.HE stands at 15.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
377.72%
10Y OCF/share CAGR above 1.5x HUH1V.HE's 157.22%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-25.47%
Negative 5Y OCF/share CAGR while HUH1V.HE is at 131.14%. Joel Greenblatt would question the firm’s operational model or cost structure.
8.92%
3Y OCF/share CAGR under 50% of HUH1V.HE's 120.55%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
11.18%
Below 50% of HUH1V.HE's 48.57%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
62.50%
5Y net income/share CAGR above 1.5x HUH1V.HE's 1.83%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
18.18%
Positive short-term CAGR while HUH1V.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
17.24%
Below 50% of HUH1V.HE's 61.36%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
19.67%
Below 50% of HUH1V.HE's 41.11%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
16.32%
3Y equity/share CAGR similar to HUH1V.HE's 16.73%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.00%
Firm’s AR is declining while HUH1V.HE shows 2.67%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.37%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.47%
Asset growth above 1.5x HUH1V.HE's 0.33%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.54%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.15%
We’re deleveraging while HUH1V.HE stands at 7.44%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-7.45%
We cut SG&A while HUH1V.HE invests at 9.28%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.